⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

CRL · Charles River Laboratories International, Inc.

$224.30 latest stored close
Detected setup Wyckoff SOS

Watch · Quality 22/100

Ask about CRL

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Commercial Services / CRL

$CRL

Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. is a large-cap Miscellaneous Commercial Services company in the Commercial Services sector with a market cap of $11B.

Buy · 77 Commercial Services Miscellaneous Commercial Services stock Stage 2 · Advancing Base 3+ Data 1h 56m ago
$224.30 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Pre-earnings setup

Wednesday, August 5, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

CRL-1.01%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. -1.03 points vs SPY.
CatalystUnavailable Stock reactionNegative Sector reactionUnavailable Opening surgeUnavailable Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $224.30 Jul 27 close
52W High $238.85 -6.1%
52W Low $144.26
Wks Since High 0w
Base Depth -6.8%
Base B3
SMA 50 $197.92
SMA 200 $185.92
Avg Vol 886,481
RS Rank 65
RS vs High -8.3%
RS Slope -0.3% ▼
Grp Rank #19/64
ADR% 3.6%
ATR(14) $8.85 (3.9%)
Rel Vol (today) 0.81×
Vol Pace N/A
U/D Vol 0.84
A/D Days 15A / 12D
A/D Rating A
VDU Bars 0/10 d
Power Trend 30d
Earnings 8d
$144.26
$238.85 85%

CRL Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for CRL.

Create Free Account
Setup Quality B 4/7 signals
Jul 24: 62 (Wyckoff SOS)Jul 24: 63 (Wyckoff SOS)Jul 27: 77 (Trend Only)Jul 27: 78 (Trend Only)Jul 28: 55 (Wyckoff SOS)55 Score trend
✓ Stage 2 · Advancing ✓ Power Trend 30d ✗ RS New High ✓ Trend 7/8 ✗ No Pattern ✗ CANSLIM 57.0 (C) ✓ Gatekeeper Base #3 (C)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$CRL · $224.30 · as of 2026-07-27 · multi-factor read
77
/ 100
Buy

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$197.92 ↑
100-day$183.98 ↑
200-day$185.92 ↑
Bullish (50 > 200)

RSI (14)

Reading57.4 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateWeakening
Histogram-2.191

Weakening — MACD slipped below its signal line. Histogram expanding.

Bollinger Bands (20,2)

%B / Width34% · 7.7%
Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.84 · Neutral
Rel volume0.81×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $228.63swing level
R · $237.24swing level
Price · $224.30now
S · $218.38swing level
S · $194.93swing level
S · $178.92swing level

Fibonacci · Uptrend swing

23.6%$216.98
38.2%$203.46
50.0%$192.52
61.8%$181.59
78.6%$166.03

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for CRL — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? 💬 Ask a Legend about CRL
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini C

Trend-template read: 7/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $224.30, MA150 $188.34, MA200 $185.92
1.2 150-day MA > 200-day MAMA150 $188.34 vs MA200 $185.92
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 64
2. Quarterly EPS growth ≥ 25%-13.8% QoQ
7/12 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high6.1% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.94%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-13.8% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 64
2/8 checks
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $224.30 vs MA200 $185.92
Failing evidence
Volume expansion above averageVolume ratio 0.81x
6/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$224.30
Distance from 52-week high6.1% below high
Failing evidence
Relative strengthRS 64
Volume vs average0.81x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$224.30
Distance from 52-week high6.1% below high
Failing evidence
Relative strengthRS 64
Volume vs average0.81x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$224.30
Distance from 52-week high6.1% below high
Failing evidence
Relative strengthRS 64
Volume vs average0.81x
3/6 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
108RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +5 A
A: 17 D: 12 Net: +565 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 3/7 met
C 3/7 SEPA
Separate score from the 8-point Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ -14%
Revenue growth ≥20% YoY -1%
Gross margin ≥30% 34%
ROE ≥17% -6%
RS rating ≥80 (leadership) 64
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -6.1%

Method Playbook

📋 Trade it like Weinstein EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
Weinstein B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Pattern Analysis

Wyckoff SOS ⚠ Extended past buy zone ⚠ Late-stage base (#4) ⚠ Not actionable yet
55.0 score
RS Score 64
Trend 7/8
CANSLIM 57.0* (C)
range low: 152.972 range high: 185.256 range pct: 0.211 sos thrust: 0.165 sos vol ratio: 1.425 sos bars ago: 20 near lps: ✗ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS

SOS: breakout above range_high=185.26, thrust=16.5%, vol=1.4x avg, lps=extended, 20 bars ago | Strong trend (7/8) | Good RS (64) | Moderate pattern (63%) | Power Trend | Stage 2 | Readiness 54/100 (early) | CANSLIM 57.0 (C) | ⚠ Extended past buy zone; Late-stage base (#4); Not actionable yet

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $224.30 vs SMA150 $188.34 / SMA200 $185.92
SMA 150 above SMA 200 SMA150 $188.34 vs SMA200 $185.92
SMA 200 trending up Slope +6.95 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $197.92
Price above SMA 50 $224.30 vs SMA50 $197.92
30%+ above 52W low +55.5% from $144.26
Within 25% of 52W high -6.1% from $238.85
RS score above 70 RS 64

Fundamentals

52W Range
85%
Mkt Cap SEC
10.8B
EPS QoQ
-14%
Rev YoY
-1%
ROE
-6%
Gross Margin
34%
D/E
0.68
EPS TTM
$-2.91
Float
48M
Insider
No Buy

Company

Legend AI snapshot
Charles River Laboratories International, Inc.
CRL · NYSE · Commercial Services · Miscellaneous Commercial Services
$224.30latest close $10.8Bmarket cap 65RS rank 55setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
C 57.0* CANSLIM * disqualified on C, M
C · Curr. EPS
34
A · Annual EPS
50
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
64
I · Inst. Spons.
56
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
88
W. Support
$146.20
W. Resist
$238.85
Weekly Structure

Scan History

20× streak
Jul 24: 62 (Wyckoff SOS)Jul 24: 63 (Wyckoff SOS)Jul 27: 77 (Trend Only)Jul 27: 78 (Trend Only)Jul 28: 55 (Wyckoff SOS)55
Jul 28
Wyckoff SOS ✓ Gate
55
Jul 27
Trend Only ✓ Gate
78 0.0%
Jul 27
Trend Only ✓ Gate
77 0.0%
Jul 24
Wyckoff SOS ✓ Gate
63 -1.0%
Jul 24
Wyckoff SOS ✓ Gate
62 -1.0%

Get the full picture on CRL

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial